127 related articles for article (PubMed ID: 1374818)
1. [Field trial for the early detection of patients with ovarian cancer].
Kobayashi H; Terao T
Rinsho Byori; 1992 Feb; 40(2):139-45. PubMed ID: 1374818
[TBL] [Abstract][Full Text] [Related]
2. [Field trial for the early detection of patients with ovarian cancer--discrimination of ovarian cancer patients by the statistical analysis using Mahalanobis' generalized distance].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y; Okada K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):174-80. PubMed ID: 1372032
[TBL] [Abstract][Full Text] [Related]
3. [Field trial of the early detection in patients with ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y; Kouda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1743-9. PubMed ID: 2480393
[TBL] [Abstract][Full Text] [Related]
4. [Serodiagnostic tests by factor analysis and stepwise discriminating analysis with tumor markers for the detection of ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1903-10. PubMed ID: 2480396
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and follow-up of ovarian cancer by a combination assay of serum sialyl SSEA-1 antigen and CA125 levels].
Iwanari O; Miyako J; Date Y; Moriyama M; Yoshino N; Kijima S; Nakayama S; Ryuhkoh K; Moriyama M; Hata T
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1256-60. PubMed ID: 2571650
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of serological tumor marker tests in patients with ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Oct; 41(10):1501-6. PubMed ID: 2573640
[TBL] [Abstract][Full Text] [Related]
8. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors.
Inoue M; Fujita M; Nakazawa A; Ogawa H; Tanizawa O
Obstet Gynecol; 1992 Mar; 79(3):434-40. PubMed ID: 1346716
[TBL] [Abstract][Full Text] [Related]
9. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
10. Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer.
Yabushita H; Masuda T; Ogawa A; Noguchi M; Ishihara M
Gynecol Oncol; 1988 Jan; 29(1):66-75. PubMed ID: 3422208
[TBL] [Abstract][Full Text] [Related]
11. [The significance of CA-50, SLX and ST-439 in lung cancer].
Hayasaka S; Takada M; Shinohara T; Imamura S; Takifuji N; Kudoh S; Matsui K; Kusunoki Y; Masuda N; Negoro S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):802-7. PubMed ID: 1681128
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
[TBL] [Abstract][Full Text] [Related]
13. [Significance of tumor markers in the treatment of patients with ovarian malignancies].
Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
[TBL] [Abstract][Full Text] [Related]
15. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
[TBL] [Abstract][Full Text] [Related]
16. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of 5'nucleotidase in primary and secondary neoplasms of the liver].
Tozzoli R; Risaliti A; Bacelle L; Perosa A; Formentini V; Bruno G; Calandra A
Chir Ital; 1988 Apr; 40(2):146-51. PubMed ID: 2458852
[TBL] [Abstract][Full Text] [Related]
18. Comparison between tissue and serum content of CA 125, CA 19-9, and carcinoembryonic antigen in ovarian tumors.
Breitenecker G; Neunteufel W; Bieglmayer C; Kölbl H; Schieder K
Int J Gynecol Pathol; 1989; 8(2):97-102. PubMed ID: 2714933
[TBL] [Abstract][Full Text] [Related]
19. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
20. [New developments in the area of markers in diagnosis and monitoring of ovarian cancer].
Kreienberg R; Melchert F
Onkologie; 1985 Oct; 8(5):253-9. PubMed ID: 2415891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
